Teva Pharm announces approval of Alprazolam E.R. Tablets

Thu Mar 1, 2007 6:22am EST

Co announces that the FDA has granted approval for the co's Abbreviated New Drug Application for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Total annual sales of this product, including brand and generic sales, are approximately $54 million, based on IMS sales data.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.